Paraguay government grants historic import permit for Medical Marijuana, Inc.'s Real Scientific Hemp Oil into Paraguay for treatment of epilepsy

Real Scientific Hemp Oil (RSHO) Cannabidiol (CBD) Hemp Oil demand grows as countries including Brazil, Mexico, Puerto Rico and Paraguay authorize its import from the U.S.

Via MARKETWIRE
May 31, 2016

SAN DIEGO, CA – Medical Marijuana, Inc. (OTC PINK: MJNA) is pleased to announce that its flagship product Real Scientific Hemp Oil (RSHO) has been authorized by Paraguay's government for import into the country as a prescription medication for refractory epilepsy.

Paraguay's first-ever import permit for RSHO marks the fourth country in Latin America, after Brazil, Puerto Rico, and Mexico, to approve MJNA's cannabidiol (CBD) hemp oil for indications including epilepsy, Parkinson's disease, chronic pain, and cancer.

The first shipment of RSHO into Paraguay was authorized for 15-year-old Mathias Alejandro Gonzalez, who was diagnosed with an autism spectrum disorder and suffers from Lennox-Gastaut Syndrome (LGS), a rare type of epilepsy that doesn't respond well to seizure medications.

"We are extremely proud of the wonderful news that RSHO has been approved for import by the government of Paraguay," states Dr. Stuart Titus, Chief Executive Officer of Medical Marijuana, Inc. "In the U.S., we enjoy the ability to easily access RSHO(tm) and many other CBD hemp oil products online. However, in other countries, we must respect their regulations and handling of cannabis-based products including hemp."

"MJNA is a 'Company of Firsts'," Titus continues. "It took many years to establish and streamline a standardized commercial system while developing the world's first CBD hemp oil pipeline. We are extremely grateful to our investors who also saw and continue to see the vision of CBD hemp oil access in the U.S. and around the world."